Skip to content
Feral Cat LogoGovInfoNow
FDA drug shortage status

Is Neostigmine Methylsulfate Injection in shortage?

Neostigmine Methylsulfate Injection is listed by FDA as being discontinued by at least one maker (updated Jan 12, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10)
    Fresenius Kabi USA, LLCBeing discontinuedUpdated Jan 12, 2026Discontinued Jan 12, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 888-386-1300

Neostigmine Methylsulfate Injection shortage questions

Is Neostigmine Methylsulfate Injection in shortage?

Neostigmine Methylsulfate Injection is listed by FDA as being discontinued by at least one maker (updated Jan 12, 2026).

What should I do if I can’t get Neostigmine Methylsulfate Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.